A
Avadel Pharmaceuticals - ADR (AVDL)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Avadel Pharmaceuticals - ADR (AVDL)
Avadel Pharmaceuticals PLC is a biopharmaceutical company. The Company’s lead product candidate, FT218, is an investigational once-nightly formulation of sodium oxybate for the treatment of excessive daytime sleepiness (EDS), and cataplexy in narcole... Read more
- USD12.94
- USD13.10
- USD12.79
- USD19.09
- -14.50%
- 88M
- 363.04k
- 945.26k
- 1.2B
- 9.50
- 23.30%
- 81.60%
Stock News
3 hours ago
East and Gulf Coast ports strike deal is not close to done: Automation still a big hurdle in ILA/USMX negotiations
CNBC
4 hours ago
Why Cisco is looking at investing in CoreWeave, a hot AI startup
MarketWatch
4 hours ago
Next steps for the Fed after strong jobs data — plus, news on health and beer stocks
CNBC
5 hours ago
Selena Gomez couldn’t afford to go to her first Disney casting—now she’s a billionaire startup founder
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
